Trazodone Hcl

Rank #169 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$92.6M

Total Cost

Share:

7,273,528

Total Claims

$92.6M

Total Cost

108,258

Prescribers

$13

Cost per Claim

1,651,826

Beneficiaries

12,463,178

30-Day Fills

$856

Avg Cost/Provider

67

Avg Claims/Provider

Share of Medicare Part D Spending

0.03%

of total Medicare Part D spending

$92.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $92.6M total

🔎 Data Overview

At $13.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Trazodone Hcl

#ProviderSpecialtyLocationClaimsCost
1Diogenes AdamesPsychiatryCarolina, PR3,438$48K
2Marc RaadInternal MedicineWolcott, CT5,143$41K
3Donald VollmerFamily PracticeHendersonville, TN4,606$34K
4Joseph AlessandroGeriatric MedicineDanielson, CT2,702$33K
5Da WangPsychiatryFlushing, NY3,998$33K
6Irving RestituyoInternal MedicineNew Bedford, MA3,528$31K
7Ruben Bravo ValverdePsychiatryBayamon, PR4,025$29K
8Simon McclurePsychiatryBridgeport, WV1,291$28K
9Erich BrueschkePhysician AssistantPhoenix, AZ1,215$28K
10Zaleskie RuizPsychiatry & NeurologyCabo Rojo, PR3,855$27K
11Rajesh AgarwalInternal MedicineMayfield Heights, OH1,874$24K
12Terence FrinksFamily PracticeTucker, GA2,847$24K
13Truc DaoPsychiatryGarden Grove, CA896$24K
14Jorge LealPain ManagementTampa, FL1,351$23K
15Joshua MintzFamily PracticeLeeds, MA3,431$23K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
166Oxycodone Myristate (Xtampza Er)$96.1M141,266
167Sevelamer Carbonate (Sevelamer Carbonate)$95.6M277,192
168Aripiprazole Lauroxil (Aristada)$93.3M31,120
169Trazodone Hcl (Trazodone Hcl)$92.6M7,273,528
170Insulin Glargine/Lixisenatide (Soliqua 100-33)$92.5M82,886
171Latanoprost (Latanoprost)$92.3M4,388,601
172Ribociclib Succinate (Kisqali)$90.3M5,978

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology